Evicenter
MarkdownMedical informationP&T meetings
Ersodetug (RZ358)

Tumor hyperinsulinism

Manufacturer
Rezolute
Launch
Not announced
Last updated
140 sources

Product information and disease descriptionProduct descriptionProduct information

Product comparison

6 evidence topics · 10 sources

Ersodetug compared with current medical therapies: manufacturer statements on site of action and limitations of comparators
Direct comparisons of ersodetug with other therapies

No evidence found.